{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018267","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.236451+00:00","generated_at":"2026-05-17T03:34:44.395422+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"bioAffinity receives US patent allowance for AI-driven lung cancer diagnostic","bullets":["USPTO allowed patent covering AI-built algorithm and flow cytometry platform for CyPath Lung test.","Patent titled 'Detection of Early-Stage Lung Cancer in Sputum using Automated Flow Cytometry and Machine Learning'.","CyPath Lung uses TCPP porphyrin and AI to detect lung cancer in sputum; clinical results: 92% sensitivity, 87% specificity, 88% accuracy.","Global patent estate now includes 18 awarded and 33 pending patents across 12 countries.","Diagnostic aims to detect early-stage lung cancer (Stage 1A) noninvasively, potentially curative."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018267","json":"https://secwatch.observer/filing/0001493152-25-018267.json","markdown":"https://secwatch.observer/filing/0001493152-25-018267.md","text":"https://secwatch.observer/filing/0001493152-25-018267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225018267/0001493152-25-018267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225018267/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:34:44.395422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}